Florida Cancer Specialists & Research Institute Weighs In With Forward-Driven Solutions To Address Current Issues in Community Oncology

FORT MYERS, Fla., April 29, 2025 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) senior leaders are sharing innovative solutions developed at the statewide practice to ensure that cancer patients have continued access to high-quality care in the communities where they live and work. At the Community Oncology Alliance (COA) 2025 Community Oncology Conference this week, FCS leaders join industry stakeholders from across the U.S. to address clinical, business, pharmacy and advocacy challenges facing community oncology practices and providers.

FCS President & Managing Physician Lucio N. Gordan, MD said "As we have for more than 40 years, we continue to keep our finger on the pulse of community-based oncology and drive meaningful change to enhance patient care and the patient experience."

Serving as presenters for the 2025 Community Oncology Conference are:

• Danielle Brown, MBA, BSN, RN, OCN, CN-BN, FCS vice president of clinical services: "Building Effective Patient Navigation Programs"
• Kiana Mehring, MBA, FCS senior director of strategic partnerships, managed care: "Practices Using Data to Engage Payers/Purchasers"
• Austin Cox, PharmD, FCS senior director of trade relations: "Preparing for the IRA's Impact on Community Oncology"

"As we shape the future of oncology, FCS will stand alongside the nation's top providers—sharing best practices, driving innovation and championing a strong, patient-centered approach to community-based cancer care," said Nathan H. Walcker, FCS chief executive officer.

During the three-day conference, FCS will also sponsor a special networking event for oncology fellows. "Supporting the next generation of oncologists is central to our mission of advancing cancer care at every level. By engaging with fellows early in their careers, we are fostering meaningful mentorship, sharing valuable insights from the perspective of community oncology providers, and shaping a future workforce that is both highly skilled and deeply committed to patient-centered care," said Dr. Gordan. "Investing in the development of oncology fellows not only strengthens the future of the field, but also ensures that innovative, compassionate care remains a cornerstone of community oncology for years to come."

The Community Oncology Alliance is dedicated to ensuring that cancer patients have access to quality, affordable and accessible cancer care in their local communities. 

About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
For more than 40 years, Florida Cancer Specialists & Research Institute (FCS) has embraced innovation to deliver world-class care and drive the dramatic transformation of oncology care through its robust clinical research program.

FCS provides patients with access to a wide range of clinical trials, positioning it as a leader in research among private oncology practices in Florida and across the country. In fact, before receiving FDA approval, the majority of new cancer drugs in the U.S. were first made available to patients through participation in clinical trials at FCS.

Our outstanding team of highly trained and dedicated physicians is committed to delivering tailored treatment plans that make the best use of cutting-edge precision oncology advancements to enhance patient outcomes.

SOURCE Florida Cancer Specialists & Research Institute